INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "TARGETED DELIVERY OF THERAPEUTIC AGENTS TO HEPATOCYTES"

GENEVA, Sept. 29 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chomeChuo-ku, Osaka-shiOsaka, 541-0045) filed a patent application (PCT/IB2025/000120) for "TARGETED DELIVERY OF THERAPEUTIC AGENTS TO HEPATOCYTES" on Mar 21, 2025. With publication no. WO/2025/196508, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KUMAR, Pawan (Takeda Development Center Americas, Inc.9625 Towne Center DriveSan Diego, CA 92121), NAZEF, Naim (Takeda Development Center Americas, Inc.9625 Towne Center DriveSan Diego, CA 92121)

Abs...